Skip to the content

Viracor Eurofins BioPharma has provided clinical development services for

9 OF THE TOP 10 Global Pharma Companies*




Viracor Eurofins BioPharma Services, a subsidiary of Viracor Eurofins, is a leader in infectious disease and vaccines, immunology and allergy testing, as well as a trusted laboratory partner, with over 35 years of specialized expertise.

We are a trusted provider of drug development solutions to pharmaceutical sponsors and contract research organizations. Our scientific research & development expertise, and clinical diagnostics experience bolsters our technological capabilities and extends the testing platforms of our offering to the clinical trial space; enabling us to bring an agnostic approach to method and platform selection in clinical trial assay development.

We are a team of highly experienced scientists and professionals, providing complex/esoteric testing and assay development for clinical research. We offer broad experience in molecular infectious disease and immunogenicity testing, along with immune response monitoring, vaccine safety/efficacy assessment, and allergy hypersensitivity testing.

At Viracor, we are dedicated to helping advance new therapies to market by providing high quality, accurate results to our pharmaceutical partners, across multiple phases of drug development. Everyday our team works collaboratively with our sponsor partners to solve some of the toughest bioassay challenges, leveraging the unique combination of state-of-the-art technology and extensive specialized expertise, that drug development companies have come to rely on for their clinical study needs. All methods are validated in accordance with the 2018 FDA Guidance for Industry Bioanalytical Methods Validation (where applicable).

Our rigorous scientific and quality processes ensure that our clients get reliable, high quality data for better decision-making, faster development and smoother submissions. Whether assisting in fulfilling regulatory requirements for assessing immunogenicity, hypersensitivity and adverse immune stimulation, or in evaluating testing to aid with subject stratification, our scientists can help build the right assay to get the data you need.


*Top ten global pharma companies by market capitalization in Q1 2019, as reported by GlobalData 09 Oct 2019.

Connect With Us